BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17729072)

  • 1. Activity limitation and quality of life in COPD.
    Jones PW
    COPD; 2007 Sep; 4(3):273-8. PubMed ID: 17729072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional status and quality of life in chronic obstructive pulmonary disease.
    Reardon JZ; Lareau SC; ZuWallack R
    Am J Med; 2006 Oct; 119(10 Suppl 1):32-7. PubMed ID: 16996897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of change in exercise tolerance on activities of daily living and quality of life in COPD: a patient's perspective.
    Cruse MA
    COPD; 2007 Sep; 4(3):279-81. PubMed ID: 17729073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD.
    ZuWallack R
    COPD; 2007 Sep; 4(3):293-7. PubMed ID: 17729076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL).
    Garrod R; Bestall JC; Paul EA; Wedzicha JA; Jones PW
    Respir Med; 2000 Jun; 94(6):589-96. PubMed ID: 10921765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life is associated with COPD severity: a comparison between the GOLD staging and the BODE index.
    Medinas Amorós M; Mas-Tous C; Renom-Sotorra F; Rubí-Ponseti M; Centeno-Flores MJ; Gorriz-Dolz MT
    Chron Respir Dis; 2009; 6(2):75-80. PubMed ID: 19411567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between exercise tolerance and other outcomes in COPD.
    Berry MJ
    COPD; 2007 Sep; 4(3):205-16. PubMed ID: 17729064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited functional performance in chronic obstructive pulmonary disease: nature, causes and measurement.
    Hill K; Goldstein RS
    COPD; 2007 Sep; 4(3):257-61. PubMed ID: 17729070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis.
    Gvozdenovic BS; Mihailovic-Vucinic V; Ilic-Dudvarski A; Zugic V; Judson MA
    Respir Med; 2008 Nov; 102(11):1636-42. PubMed ID: 18691860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the effects of COPD on the patient.
    Jones P; Lareau S; Mahler DA
    Respir Med; 2005 Dec; 99 Suppl B():S11-8. PubMed ID: 16236492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity of the BODE index.
    Medinas-Amorós M; Alorda C; Renom F; Rubí M; Centeno J; Ferrer V; Gorriz T; Mas-Tous C; Ramis F
    Chron Respir Dis; 2008; 5(1):7-11. PubMed ID: 18303096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endurance or resistance training in primary care after in-patient rehabilitation for COPD?
    Skumlien S; Aure Skogedal E; Skrede Ryg M; Bjørtuft Ø
    Respir Med; 2008 Mar; 102(3):422-9. PubMed ID: 18037283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of functional independence measure in rehabilitation of inpatients with respiratory failure.
    Pasqua F; Biscione GL; Crigna G; Gargano R; Cardaci V; Ferri L; Cesario A; Clini E
    Respir Med; 2009 Mar; 103(3):471-6. PubMed ID: 18977645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improved exercise tolerance can be achieved in chronic obstructive pulmonary disease (COPD) by means of non-pharmacological treatment].
    Wijkstra PJ; Wempe JB; van der Bij W; Klinkenberg T; ten Hacken NH; Köeter GH
    Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1213-7. PubMed ID: 16796170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is exercise important in chronic obstructive pulmonary disease?
    Make B; Casaburi R
    COPD; 2007 Sep; 4(3):185-9. PubMed ID: 17729061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical utility of the GOLD classification of COPD disease severity in pulmonary rehabilitation.
    Huijsmans RJ; de Haan A; ten Hacken NN; Straver RV; van't Hul AJ
    Respir Med; 2008 Jan; 102(1):162-71. PubMed ID: 17881207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
    Ozgur ES; Atis S; Kanik A
    Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study.
    Maleki-Yazdi MR; Lewczuk CK; Haddon JM; Choudry N; Ryan N
    COPD; 2007 Dec; 4(4):313-20. PubMed ID: 18027158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the impact of pulmonary rehabilitation on functional status in COPD.
    Laviolette L; Bourbeau J; Bernard S; Lacasse Y; Pepin V; Breton MJ; Baltzan M; Rouleau M; Maltais F
    Thorax; 2008 Feb; 63(2):115-21. PubMed ID: 17901158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated waon therapy improves pulmonary hypertension during exercise in patients with severe chronic obstructive pulmonary disease.
    Umehara M; Yamaguchi A; Itakura S; Suenaga M; Sakaki Y; Nakashiki K; Miyata M; Tei C
    J Cardiol; 2008 Apr; 51(2):106-13. PubMed ID: 18522783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.